Skip to content
Application 200626
- Type
- ANDA
- Sponsor
- CIPLA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | CAPSULE;ORAL | EQ 100MG BASE | No | No |
| 002 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | CAPSULE;ORAL | EQ 150MG BASE | No | No |
| 003 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | CAPSULE;ORAL | EQ 200MG BASE | No | No |
| 004 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | CAPSULE;ORAL | EQ 300MG BASE | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 69097-443 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-443 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-443 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-443 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-444 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-444 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-444 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-444 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-445 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-445 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-445 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-445 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-446 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-446 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-446 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 69097-446 | ATAZANAVIR | Atazanavir | Cipla USA Inc. | ANDA | Current |
| 70518-2832 | ATAZANAVIR | Atazanavir | REMEDYREPACK INC. | ANDA | Current |
| 70518-2832 | ATAZANAVIR | Atazanavir | REMEDYREPACK INC. | ANDA | Current |